Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PARP7, NT (TCDD-inducible Poly [ADP-ribose] Polymerase, Poly [ADP-ribose] Polymerase 7, PARP-7, TIPARP) (MaxLight 750)](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
MBS6492190-01 0.1 mL
PARP7, NT (TCDD-inducible Poly [ADP-ribose] Polymerase, Poly [ADP-ribose] Polymerase 7, PARP-7, TIPARP) (MaxLight 750)
Sign In for Pricing
View Details